Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences 2. Immunogenicity in poor responders to hepatitis B vaccines
- 1 November 1997
- Vol. 15 (16) , 1732-1736
- https://doi.org/10.1016/s0264-410x(97)00118-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccineVaccine, 1995
- Response to an Extra Dose of Hepatitis B Vaccine and Specific Antibody Persistence in Non-Responders to Primary ImmunizationScandinavian Journal of Gastroenterology, 1995
- Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testingVaccine, 1994
- Immunisation of staff of a regional Blood Transfusion Centre with a recombinant hepatitis B vaccineJournal of Infection, 1991
- Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and ageEpidemiology and Infection, 1989
- Genetic Prediction of Nonresponse to Hepatitis B VaccineNew England Journal of Medicine, 1989
- Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cellsHuman Immunology, 1988
- Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.The Journal of Experimental Medicine, 1984
- Hepatitis B Vaccine in Medical Staff of Hemodialysis UnitsNew England Journal of Medicine, 1982
- Hepatitis B VaccineNew England Journal of Medicine, 1980